Cyngn Inc. (the "Company" or "Cyngn") (Nasdaq: CYN) today announced that it will present at the upcoming Singular Research's Emerging Growth & Value Alpha Leaders Webinar on February 22, 2024 at...

AGTC-501 was generally safe and well-tolerated and showed robust improvements in visual function at the 12-month analysis Pivotal Phase 2/3 VISTA trial for AGTC-501 in XLRP expected to begin in H1...

AeroBand, the technology brand dedicated to the global expansion of smart musical instruments, created waves at the recently concluded Nammshow 2024 by unveiling its highly anticipated AeroBand...

DEEPX (CEO Lokwon, Kim), a frontrunner in AI chip technology, defines the critical technology for commercializing generative AI as the 'Federated Operation of LLM' and is advancing in its...

XNK Therapeutics AB ("XNK") today announced that Johan Liwing, CEO, will present the company at the Redeye Regenerative Medicine/Cell Therapy event on February 14. XNK's presentation starts at...